These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12538713)

  • 1. Induction of antigen-specific CTL responses using antigens conjugated to short peptide vectors.
    Day FH; Zhang Y; Clair P; Grabstein KH; Mazel M; Rees AR; Kaczorek M; Temsamani J
    J Immunol; 2003 Feb; 170(3):1498-503. PubMed ID: 12538713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope-specific cytotoxic T lymphocyte induction by minigene DNA immunization.
    Iwasaki A; Dela Cruz CS; Young AR; Barber BH
    Vaccine; 1999 Apr; 17(15-16):2081-8. PubMed ID: 10217610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty-virus-like particles.
    Layton GT; Harris SJ; Myhan J; West D; Gotch F; Hill-Perkins M; Cole JS; Meyers N; Woodrow S; French TJ; Adams SE; Kingsman AJ
    Immunology; 1996 Feb; 87(2):171-8. PubMed ID: 8698376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creating CTL targets with epitope-linked beta 2-microglobulin constructs.
    Uger RA; Barber BH
    J Immunol; 1998 Feb; 160(4):1598-605. PubMed ID: 9469415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential processing and presentation of the H-2D(b)-restricted epitope from two different strains of influenza virus nucleoprotein.
    Potter P; Tourdot S; Blanchard T; Smith GL; Gould KG
    J Gen Virol; 2001 May; 82(Pt 5):1069-1074. PubMed ID: 11297681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient delivery of Antennapedia homeodomain fused to CTL epitope with liposomes into dendritic cells results in the activation of CD8+ T cells.
    Chikh GG; Kong S; Bally MB; Meunier JC; Schutze-Redelmeier MP
    J Immunol; 2001 Dec; 167(11):6462-70. PubMed ID: 11714813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA fusion vaccine designed to induce cytotoxic T cell responses against defined peptide motifs: implications for cancer vaccines.
    Rice J; Elliott T; Buchan S; Stevenson FK
    J Immunol; 2001 Aug; 167(3):1558-65. PubMed ID: 11466377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple antigen-specific processing pathways for activating naive CD8+ T cells in vivo.
    Norbury CC; Princiotta MF; Bacik I; Brutkiewicz RR; Wood P; Elliott T; Bennink JR; Yewdell JW
    J Immunol; 2001 Apr; 166(7):4355-62. PubMed ID: 11254689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing the efficacy of epitope-directed DNA vaccination.
    Wolkers MC; Toebes M; Okabe M; Haanen JB; Schumacher TN
    J Immunol; 2002 May; 168(10):4998-5004. PubMed ID: 11994451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTL epitopes identified with a defective recombinant adenovirus expressing measles virus nucleoprotein and evaluation of their protective capacity in mice.
    Schadeck EB; Partidos CD; Fooks AR; Obeid OE; Wilkinson GW; Stephenson JR; Steward MW
    Virus Res; 1999 Dec; 65(1):75-86. PubMed ID: 10564754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes.
    Nelson D; Bundell C; Robinson B
    J Immunol; 2000 Dec; 165(11):6123-32. PubMed ID: 11086045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopeptide particles as the immunologically active component of CTL inducing vaccines.
    Tsunoda I; Sette A; Fujinami RS; Oseroff C; Ruppert J; Dahlberg C; Southwood S; Arrhenius T; Kuang LQ; Kubo RT; Chesnut RW; Ishioka GY
    Vaccine; 1999 Feb; 17(7-8):675-85. PubMed ID: 10067673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of T-cell responses to peptides and lipopeptides with MHC class I binding motifs derived from the amino acid sequence of the 19-kDa lipoprotein of Mycobacterium tuberculosis.
    Fonseca DP; Joosten D; Snippe H; Verheul AF
    Mol Immunol; 2000 Jun; 37(8):413-22. PubMed ID: 11090876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides.
    Franke ED; Corradin G; Hoffman SL
    J Immunol; 1997 Oct; 159(7):3424-33. PubMed ID: 9317141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans.
    Geluk A; van Meijgaarden KE; Franken KL; Drijfhout JW; D'Souza S; Necker A; Huygen K; Ottenhoff TH
    J Immunol; 2000 Dec; 165(11):6463-71. PubMed ID: 11086086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. 1986.
    Townsend AR; Rothbard J; Gotch FM; Bahadur G; Wraith D; McMichael AJ
    J Immunol; 2006 May; 176(9):5141-50. PubMed ID: 16621977
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiepitope Trojan antigen peptide vaccines for the induction of antitumor CTL and Th immune responses.
    Lu J; Higashimoto Y; Appella E; Celis E
    J Immunol; 2004 Apr; 172(7):4575-82. PubMed ID: 15034075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus.
    Basler M; Youhnovski N; Van Den Broek M; Przybylski M; Groettrup M
    J Immunol; 2004 Sep; 173(6):3925-34. PubMed ID: 15356141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs.
    DiBrino M; Tsuchida T; Turner RV; Parker KC; Coligan JE; Biddison WE
    J Immunol; 1993 Dec; 151(11):5930-5. PubMed ID: 7504010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA vaccines, combining form of antigen and method of delivery to raise a spectrum of IFN-gamma and IL-4-producing CD4+ and CD8+ T cells.
    Oran AE; Robinson HL
    J Immunol; 2003 Aug; 171(4):1999-2005. PubMed ID: 12902504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.